Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Patients With Atherosclerosis (TRA 2°P - TIMI 50) (P04737)

Clinical trial NCT00526474 · COMPLETED

Trial details

NCT number: NCT00526474
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Atherosclerosis Ischemia Myocardial Infarction Cerebrovascular Accident Peripheral Arterial Disease

Start date: 2007-09-01
Primary completion: 2011-12-01
Enrollment: 26449

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.